Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 204

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis

Anzini, Marco, Merlo, Marco, Sabbadini, Gastone, Barbati, Giulia, Finocchiaro, Gherardo, Pinamonti, Bruno, Salvi, Alessandro, Perkan, Andrea, Di Lenarda, Andrea, Bussani, Rossana, Bartunek, Jozef, Sinagra, Gianfranco·2013·Circulation

Abstract

Background—: Active myocarditis is characterized by large heterogeneity of clinical presentation and evolution. This study describes the characteristics and the long-term evolution of a large sample of patients with biopsy-proven active myocarditis, looking for accessible and valid early predictors of long-term prognosis. Methods and Results—: From 1981 to 2009, 82 patients with biopsy-proven active myocarditis were consecutively enrolled and followed-up for 147±107 months. All patients underwent clinical and echocardiographic evaluation at baseline and at 6 months. At this time, improvement/normality of left ventricular ejection fraction (LVEF), defined as a LVEF increase > 20 percentage points or presence of LVEF≥50%, was assessed. At baseline, left ventricular dysfunction (LVEF<50%) and left atrium enlargement were independently associated with long-term heart transplantation–free survival, regardless of the clinical pattern of disease onset. At 6 months, improvement/normality of LVEF was observed in 53% of patients. Persistence of New York Heart Association III to IV classes, left atrium enlargement, and improvement/normality of LVEF at 6 months emerged as independent predictors of long-term outcome. Notably, the short-term reevaluation showed a significant incremental prognostic value in comparison with the baseline evaluation (baseline model versus 6 months model: area under the curve 0.79 versus 0.90, P =0.03). Conclusions—: Baseline left ventricular function is a marker for prognosis regardless of the clinical pattern of disease onset, and its reassessment at 6 months appears useful for assessing longer-term outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.113.003092

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 204

Metadata

Authors
Anzini, M., Merlo, M., Sabbadini, G., Barbati, G., Finocchiaro, G., Pinamonti, B., Salvi, A., Perkan, A., Di Lenarda, A., Bussani, R., Bartunek, J., & Sinagra, G.
Venue
Circulation
Published
2013-11-26
Volume
128
Issue
22
Pages
2384-2394
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2077566335
Cited by
204
References
4
FWCI
5.93
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis. https://app.cochat.ai/papers/10.1161/circulationaha.113.003092
The paper
Anzini, M., Merlo, M., Sabbadini, G., Barbati, G., Finocchiaro, G., Pinamonti, B., Salvi, A., Perkan, A., Di Lenarda, A., Bussani, R., Bartunek, J., & Sinagra, G. (2013). Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis. Circulation. https://doi.org/10.1161/circulationaha.113.003092

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.